₹ 72.70
-2.20 (-2.94%)
BSE
I
Ishita Drugs & Indus
₹ 72.70
BSE
Ishita Drugs & Indus Fundamentals
Company Valuation
Market Cap (₹ Cr.)
22
PE Ratio
31.00
PB Ratio
1.87
Dividend Yield
-
ROE
6.73%
ROCE
9.81%
Book Value (₹)
40.00
Face Value (₹)
10.00
Analyse ISHITADR with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 49.96% | 50.04% | 50.04% | 50.04% | 50.04% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 46.63% | 46.33% | 47.37% | 47.89% | 48.33% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
ISHITADR Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
524400
NSE Scrip Name
ISHITADR
ISIN
INE806D01016

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






